<unk>  is used in the treatment of chronic Hepatitis C infection. It is used in the following HCV subtypes: genotype 1a, genotype 1b, genotype 1 of unknown subtype, and genotype 1 mixed infection without cirrhosis or with compensated cirrhosis. In the European Union,<unk>  (Exviera) is always used in combination with another medicine, ombitasvir/paritaprevir/ritonavir (Viekirax) for the treatment of hepatitis C virus genotypes 1a and 1b. Some people taking<unk>  are also treated with another antiviral medicine, ribavirin, in addition to ombitasvir/paritaprevir/ritonavir. In the United States,<unk>  is co-packaged with ombitasvir/paritaprevir/ritonavir (Viekira Pak) and the combination is indicated for the treatment of adults with chronic hepatitis C virus genotype 1b without cirrhosis or with compensated cirrhosis. The co-packaged<unk>  and ombitasvir/paritaprevir/ritonavir is used in combination with ribavirin for the treatment of adults with chronic hepatitis C virus genotype 1a without cirrhosis or with compensated cirrhosis.
Dasabuvir
Telaprevir
Fosamprenavir
Coronavir
Sofosbuvir
Abacavir
Enfuvirtide
Indinavir